These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 26245379)

  • 1. Structural insights into µ-opioid receptor activation.
    Huang W; Manglik A; Venkatakrishnan AJ; Laeremans T; Feinberg EN; Sanborn AL; Kato HE; Livingston KE; Thorsen TS; Kling RC; Granier S; Gmeiner P; Husbands SM; Traynor JR; Weis WI; Steyaert J; Dror RO; Kobilka BK
    Nature; 2015 Aug; 524(7565):315-21. PubMed ID: 26245379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propagation of conformational changes during μ-opioid receptor activation.
    Sounier R; Mas C; Steyaert J; Laeremans T; Manglik A; Huang W; Kobilka BK; Déméné H; Granier S
    Nature; 2015 Aug; 524(7565):375-8. PubMed ID: 26245377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the µ-opioid receptor-G
    Koehl A; Hu H; Maeda S; Zhang Y; Qu Q; Paggi JM; Latorraca NR; Hilger D; Dawson R; Matile H; Schertler GFX; Granier S; Weis WI; Dror RO; Manglik A; Skiniotis G; Kobilka BK
    Nature; 2018 Jun; 558(7711):547-552. PubMed ID: 29899455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational insights into the G-protein-biased activation and inactivation mechanisms of the μ opioid receptor.
    Cheng JX; Cheng T; Li WH; Liu GX; Zhu WL; Tang Y
    Acta Pharmacol Sin; 2018 Jan; 39(1):154-164. PubMed ID: 29188799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.
    Manglik A; Kruse AC; Kobilka TS; Thian FS; Mathiesen JM; Sunahara RK; Pardo L; Weis WI; Kobilka BK; Granier S
    Nature; 2012 Mar; 485(7398):321-6. PubMed ID: 22437502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of β-arrestin recruitment by the μ-opioid G protein-coupled receptor.
    Mafi A; Kim SK; Goddard WA
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16346-16355. PubMed ID: 32601232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method.
    Wang YT; Chan YH
    Sci Rep; 2017 Aug; 7(1):7828. PubMed ID: 28798303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand based conformational space studies of the μ-opioid receptor.
    Sena DM; Cong X; Giorgetti A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129838. PubMed ID: 33373630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.
    Ring AM; Manglik A; Kruse AC; Enos MD; Weis WI; Garcia KC; Kobilka BK
    Nature; 2013 Oct; 502(7472):575-579. PubMed ID: 24056936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling of salsolinol, a full G
    Berríos-Cárcamo P; Rivera-Meza M; Herrera-Marschitz M; Zapata-Torres G
    Chem Biol Drug Des; 2019 Aug; 94(2):1467-1477. PubMed ID: 30920734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural features of β2 adrenergic receptor: crystal structures and beyond.
    Bang I; Choi HJ
    Mol Cells; 2015; 38(2):105-11. PubMed ID: 25537861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing Allosteric Regulation Mechanism of W7.35 on Agonist-Induced Activity for μOR by Mutation Simulation.
    Zhang F; Chen X; Chen J; Xu Y; Li S; Guo Y; Pu X
    J Chem Inf Model; 2022 Nov; 62(21):5120-5135. PubMed ID: 34779608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.
    Noha SM; Schmidhammer H; Spetea M
    ACS Chem Neurosci; 2017 Jun; 8(6):1327-1337. PubMed ID: 28125215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72.
    Munro TA
    BMC Biol; 2023 Oct; 21(1):213. PubMed ID: 37817141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How μ-opioid receptor recognizes fentanyl.
    Vo QN; Mahinthichaichan P; Shen J; Ellis CR
    Nat Commun; 2021 Feb; 12(1):984. PubMed ID: 33579956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing biased activation of mu-opioid receptor by the biased agonist PZM21 using all atom molecular dynamics simulation.
    Liao S; Tan K; Floyd C; Bong D; Pino MJ; Wu C
    Life Sci; 2021 Mar; 269():119026. PubMed ID: 33444617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
    DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
    Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and allosteric modulation of a muscarinic acetylcholine receptor.
    Kruse AC; Ring AM; Manglik A; Hu J; Hu K; Eitel K; Hübner H; Pardon E; Valant C; Sexton PM; Christopoulos A; Felder CC; Gmeiner P; Steyaert J; Weis WI; Garcia KC; Wess J; Kobilka BK
    Nature; 2013 Dec; 504(7478):101-6. PubMed ID: 24256733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of intracellular allosteric β
    Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
    Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.